Piper Sandler Companies (NYSE: PIPR) is a U.S.-based investment banking and institutional securities firm headquartered in Minneapolis. Through its broker-dealer Piper Sandler & Co., the firm provides mergers and acquisitions advice, equity and debt capital markets underwriting, private placements, restructuring, and institutional sales, trading, and equity research across multiple industries worldwide.
Within the chemicals and advanced materials value chain, Piper Sandler advises specialty and commodity chemical producers, custom and toll manufacturers, performance materials businesses, and chemical distributors on strategic transactions and financing. Coverage includes cross-border M&A, carve-outs, divestitures, and growth capital raising, supported by sector-focused teams with knowledge of end markets such as electronics, aerospace, life sciences, and industrials.
None yet. When a new project in the record names Piper Sandler as owner, partner or investor, it shows here.
Ultra‑pure sulphur dioxide and derivatives unit with plants in Texas and Ontario sold for $190 million; transaction was first announced in May 2026.
Sale covers ultra-pure sulphur dioxide and derivatives business with plants in Texas and Ontario; deal valued at $190M; expected to close by end-June 2026; operations unchanged until completion.
CABB shifts focus to Pharma and Life Science, selling Jayhawk for $150M. Anupam Rasayan aims to expand its US presence and performance materials business.
CABB shifts focus to Pharma and Life Science, selling Jayhawk for $150M. Anupam Rasayan aims to expand in the US and enhance its performance materials business. Transaction closes in January.
